Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
AbbVie
ABBV
|
$683M |
| 2 |
RTX Corp
RTX
|
$615M |
| 3 |
Meta Platforms (Facebook)
META
|
$553M |
| 4 |
Eli Lilly
LLY
|
$389M |
| 5 |
T-Mobile US
TMUS
|
$386M |
Top Sells
| 1 |
Amazon
AMZN
|
$945M |
| 2 |
Microsoft
MSFT
|
$572M |
| 3 |
Gilead Sciences
GILD
|
$467M |
| 4 |
Merck
MRK
|
$368M |
| 5 |
Intel
INTC
|
$361M |
Sector Composition
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.39% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Mondelez International
MDLZ
$79.5B
| $656M | 0.27% | 12,829,160 -1,968,578 | -13% | -$101M |
|
77
TJX Companies
TJX
$152B
| $643M | 0.26% | 12,724,168 +2,127,645 | +20% | +$108M |
|
78
Boeing
BA
$177B
| $640M | 0.26% | 3,493,913 +267,900 | +8% | +$49.1M |
|
79
Danaher
DHR
$147B
| $635M | 0.26% | 3,589,728 -305,755 | -8% | -$54.1M |
|
80
Chubb
CB
$110B
| $633M | 0.26% | 5,001,648 +465,487 | +10% | +$58.9M |
|
|
81
T-Mobile US
TMUS
$284B
| $633M | 0.26% | 6,076,147 +3,702,833 | +156% | +$386M |
|
82
Crown Castle
CCI
$43.2B
| $623M | 0.25% | 3,723,982 +8,315 | +0.2% | +$1.39M |
|
83
Lam Research
LRCX
$127B
| $618M | 0.25% | 1,910,232 -202,144 | -10% | -$65.4M |
|
84
Medtronic
MDT
$119B
| $612M | 0.25% | 6,671,752 -333,952 | -5% | -$30.6M |
|
85
Advanced Micro Devices
AMD
$264B
| $607M | 0.25% | 11,532,429 +841,525 | +8% | +$44.3M |
|
86
Starbucks
SBUX
$100B
| $603M | 0.25% | 8,191,343 +1,496,845 | +22% | +$110M |
|
87
Marsh & McLennan
MMC
$101B
| $602M | 0.25% | 5,610,220 -252,636 | -4% | -$27.1M |
|
88
CVS Health
CVS
$92.8B
| $597M | 0.24% | 9,196,421 -1,440,977 | -14% | -$93.6M |
|
89
Elevance Health
ELV
$71.8B
| $597M | 0.24% | 2,271,105 -58,304 | -3% | -$15.3M |
|
90
Lockheed Martin
LMT
$106B
| $574M | 0.23% | 1,573,706 -76,382 | -5% | -$27.9M |
|
91
DuPont de Nemours
DD
$32.2B
| $572M | 0.23% | 10,766,107 +3,043,153 | +39% | +$162M |
|
92
Roper Technologies
ROP
$56.6B
| $562M | 0.23% | 1,446,757 -298,534 | -17% | -$116M |
|
93
Target
TGT
$43.6B
| $519M | 0.21% | 4,323,857 -1,016,888 | -19% | -$122M |
|
94
Monster Beverage
MNST
$60.9B
| $502M | 0.2% | 7,244,699 -2,614,663 | -27% | -$181M |
|
95
Zimmer Biomet
ZBH
$21B
| $490M | 0.2% | 4,107,683 +282,765 | +7% | +$33.8M |
|
|
96
Gilead Sciences
GILD
$140B
| $490M | 0.2% | 6,371,731 -6,067,783 | -49% | -$467M |
|
97
Humana
HUM
$36.5B
| $482M | 0.2% | 1,243,462 -62,333 | -5% | -$24.2M |
|
98
American Electric Power
AEP
$59.4B
| $475M | 0.19% | 5,958,813 -511,518 | -8% | -$40.7M |
|
99
Uber
UBER
$196B
| $474M | 0.19% | 15,238,744 +5,369,305 | +54% | +$167M |
|
100
Chipotle Mexican Grill
CMG
$56.5B
| $472M | 0.19% | 448,641 -57,528 | -11% | -$60.5M |
|